These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 16499286

  • 1. Nature's clarion call of antibacterial resistance: are we listening?
    Theuretzbacher U, Toney JH.
    Curr Opin Investig Drugs; 2006 Feb; 7(2):158-66. PubMed ID: 16499286
    [Abstract] [Full Text] [Related]

  • 2. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ, Bradford PA.
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [Abstract] [Full Text] [Related]

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 4. Future antibiotics scenarios: is the tide starting to turn?
    Theuretzbacher U.
    Int J Antimicrob Agents; 2009 Jul; 34(1):15-20. PubMed ID: 19342202
    [Abstract] [Full Text] [Related]

  • 5. Antibacterial drug discovery in the 21st century.
    Bush K.
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():10-7. PubMed ID: 15522035
    [Abstract] [Full Text] [Related]

  • 6. What's new in antibiotic resistance? Focus on beta-lactamases.
    Babic M, Hujer AM, Bonomo RA.
    Drug Resist Updat; 2006 Jun; 9(3):142-56. PubMed ID: 16899402
    [Abstract] [Full Text] [Related]

  • 7. Combination drugs, an emerging option for antibacterial therapy.
    Cottarel G, Wierzbowski J.
    Trends Biotechnol; 2007 Dec; 25(12):547-55. PubMed ID: 17997179
    [Abstract] [Full Text] [Related]

  • 8. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
    Thomson CJ, Power E, Ruebsamen-Waigmann H, Labischinski H.
    Curr Opin Microbiol; 2004 Oct; 7(5):445-50. PubMed ID: 15451498
    [Abstract] [Full Text] [Related]

  • 9. What's new on the antimicrobial horizon?
    Song JH.
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521
    [Abstract] [Full Text] [Related]

  • 10. Fighting bacterial infections-future treatment options.
    Fernebro J.
    Drug Resist Updat; 2011 Apr; 14(2):125-39. PubMed ID: 21367651
    [Abstract] [Full Text] [Related]

  • 11. β-Lactam and glycopeptide antibiotics: first and last line of defense?
    Jovetic S, Zhu Y, Marcone GL, Marinelli F, Tramper J.
    Trends Biotechnol; 2010 Dec; 28(12):596-604. PubMed ID: 20970210
    [Abstract] [Full Text] [Related]

  • 12. Novel agents to inhibit microbial virulence and pathogenicity.
    Escaich S.
    Expert Opin Ther Pat; 2010 Oct; 20(10):1401-18. PubMed ID: 20718591
    [Abstract] [Full Text] [Related]

  • 13. Update on the antibacterial resistance crisis.
    Croft AC, D'Antoni AV, Terzulli SL.
    Med Sci Monit; 2007 Jun; 13(6):RA103-18. PubMed ID: 17534243
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM.
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [Abstract] [Full Text] [Related]

  • 15. Prospects and challenges of developing new agents for tough Gram-negatives.
    Meyer AL.
    Curr Opin Pharmacol; 2005 Oct; 5(5):490-4. PubMed ID: 16084769
    [Abstract] [Full Text] [Related]

  • 16. The need for new antibiotics.
    Livermore DM.
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():1-9. PubMed ID: 15522034
    [Abstract] [Full Text] [Related]

  • 17. Selection of antibiotic-resistant pathogens in the community.
    Yagupsky P.
    Pediatr Infect Dis J; 2006 Oct; 25(10):974-6. PubMed ID: 17006309
    [Abstract] [Full Text] [Related]

  • 18. Postgenomic strategies in antibacterial drug discovery.
    Brötz-Oesterhelt H, Sass P.
    Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. New strategies for combating multidrug-resistant bacteria.
    Wright GD, Sutherland AD.
    Trends Mol Med; 2007 Jun; 13(6):260-7. PubMed ID: 17493872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.